The three-year implantable products contract between subsidiary TRX BioSurgery and healthcare improvement company Premier kicks off July 1, building off of the companies’ ‘Breakthrough Technology Agreement’ signed in December 2016.
DermaPure is a decellurized human dermis used in acute and chronic wound care, orthopedic trauma and dental applications. After TRX formed an exclusive distribution agreement with ARMS medical, DermaPure may also be used in urogynecology and urology.
More articles on biologics:
4 things to know about Datum Orthobiologics, a newly formed company
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.